Wynim-P Tablet is a combination analgesic and anti-inflammatory medication containing Nimesulide 100 mg and Paracetamol 325 mg. Nimesulide, a selective COX-2 inhibitor, provides effective relief from pain and inflammation by reducing the synthesis of prostaglandins, while Paracetamol offers analgesic and antipyretic effects through central inhibition of prostaglandin synthesis. This combination is indicated for the management of acute pain, including musculoskeletal disorders, dental pain, postoperative pain, and primary dysmenorrhea. Wynim-P Tablet is particularly useful when inflammation is a significant component of the clinical condition. It is generally well tolerated; however, caution is advised in patients with hepatic or renal impairment, as both components are metabolized hepatically and excreted renally. Use should be avoided in individuals with known hypersensitivity to either component or other NSAIDs. The medication should be administered with food to minimize gastrointestinal irritation. Prolonged use should be avoided to reduce the risk of adverse effects such as gastrointestinal bleeding or hepatotoxicity. Wynim-P Tablet should be used under medical supervision, adhering strictly to the prescribed dosage and duration to ensure safety and efficacy.